Company Filing History:
Years Active: 1999-2002
Title: The Innovative Contributions of Stefan Carrel
Introduction
Stefan Carrel is a notable inventor based in Epalinges, Switzerland. He has made significant contributions to the field of cancer research, particularly through his innovative work on tumor rejection antigens.
Latest Patents
Stefan Carrel holds 5 patents that focus on immunogenic compositions related to tumor rejection antigens. His latest patents include the development of isolated cDNA molecules that encode the tumor rejection antigen precursor MAGE-10, along with the protein itself and specific antibodies. These inventions are crucial for advancing cancer treatment and understanding immune responses.
Career Highlights
Carrel is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to push the boundaries of cancer research. His work has been instrumental in developing new therapeutic strategies aimed at enhancing the immune system's ability to fight tumors.
Collaborations
Stefan Carrel has collaborated with esteemed colleagues such as Donata Rimoldi and Victor Jongeneel. These partnerships have fostered a collaborative environment that enhances the research output and innovation in cancer therapies.
Conclusion
Stefan Carrel's contributions to cancer research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to inspire advancements in immunotherapy and cancer treatment.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.